Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole: Final results
Reinisch M, Nusch A, Decker T, Hartkopf A, Heinrich BJ, Kurbacher CM, Fuchs R, Tesch H, Krabisch P, Brucker SY, Fehm T, Janni W, Kuemmel S, Luftner D, Schneeweiss A, Schuler M, Voges C, Schubert J, Fasching P (2021)
Publication Type: Conference contribution
Publication year: 2021
Journal
Publisher: AMER ASSOC CANCER RESEARCH
City/Town: PHILADELPHIA
Conference Proceedings Title: CANCER RESEARCH
DOI: 10.1158/1538-7445.sabcs20-ps10-31
Authors with CRIS profile
Involved external institutions
Universitätsklinikum Ulm
Germany (DE)
Kliniken Essen-Mitte
Germany (DE)
Universitätsklinikum Düsseldorf
Germany (DE)
Centrum für Hämatologie und Onkologie Bethanien
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Medizinisches Zentrum Bonn Friedensplatz
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
Universitätsklinikum Heidelberg
Germany (DE)
Novartis AG
Switzerland (CH)
Universitätsklinikum Essen
Germany (DE)
Klinikum Chemnitz
Germany (DE)
Germany (DE)
Kliniken Essen-Mitte
Germany (DE)
Universitätsklinikum Düsseldorf
Germany (DE)
Centrum für Hämatologie und Onkologie Bethanien
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Medizinisches Zentrum Bonn Friedensplatz
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
Universitätsklinikum Heidelberg
Germany (DE)
Novartis AG
Switzerland (CH)
Universitätsklinikum Essen
Germany (DE)
Klinikum Chemnitz
Germany (DE)
How to cite
APA:
Reinisch, M., Nusch, A., Decker, T., Hartkopf, A., Heinrich, B.J., Kurbacher, C.M.,... Fasching, P. (2021). Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole: Final results. In CANCER RESEARCH. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
MLA:
Reinisch, Mattea, et al. "Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole: Final results." Proceedings of the CANCER RESEARCH PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2021.
BibTeX: Download